WuXi Biologics And WuXi AppTec Plan $2.8 Billion Investment In Singapore Facilities
Frontera Therapeutics completed a $160 million Series B funding to support its AAV programs.
Source: seekingalpha.com
Stay updated with breaking news from China Accelerator. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Frontera Therapeutics completed a $160 million Series B funding to support its AAV programs.